195 related articles for article (PubMed ID: 27179345)
21. Smokeless tobacco increases aneuploidy in oral HPV16 E6/E7-transformed keratinocytes in vitro.
Merne M; Rautava J; Ruutu M; Syrjänen S
J Oral Pathol Med; 2014 Oct; 43(9):685-90. PubMed ID: 24761760
[TBL] [Abstract][Full Text] [Related]
22. HPV immortalization of human oral epithelial cells: a model for carcinogenesis.
Oda D; Bigler L; Lee P; Blanton R
Exp Cell Res; 1996 Jul; 226(1):164-9. PubMed ID: 8660952
[TBL] [Abstract][Full Text] [Related]
23. Latent and lytic Epstein-Barr virus replication strategies.
Tsurumi T; Fujita M; Kudoh A
Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus latency type and spontaneous reactivation predict lytic induction levels.
Phan AT; Fernandez SG; Somberg JJ; Keck KM; Miranda JL
Biochem Biophys Res Commun; 2016 May; 474(1):71-75. PubMed ID: 27091426
[TBL] [Abstract][Full Text] [Related]
25. Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells.
Kyo S; Klumpp DJ; Inoue M; Kanaya T; Laimins LA
J Gen Virol; 1997 Feb; 78 ( Pt 2)():401-11. PubMed ID: 9018063
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes.
Balagué C; Noya F; Alemany R; Chow LT; Curiel DT
J Virol; 2001 Aug; 75(16):7602-11. PubMed ID: 11462032
[TBL] [Abstract][Full Text] [Related]
27. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr Virus Lytic Cycle Reactivation.
McKenzie J; El-Guindy A
Curr Top Microbiol Immunol; 2015; 391():237-61. PubMed ID: 26428377
[TBL] [Abstract][Full Text] [Related]
29. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium.
Tugizov S; Herrera R; Veluppillai P; Greenspan J; Greenspan D; Palefsky JM
J Virol; 2007 Jun; 81(11):5484-96. PubMed ID: 17376918
[TBL] [Abstract][Full Text] [Related]
31. Cellular STAT3 functions via PCBP2 to restrain Epstein-Barr Virus lytic activation in B lymphocytes.
Koganti S; Clark C; Zhi J; Li X; Chen EI; Chakrabortty S; Hill ER; Bhaduri-McIntosh S
J Virol; 2015 May; 89(9):5002-11. PubMed ID: 25717101
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus: a master epigenetic manipulator.
Scott RS
Curr Opin Virol; 2017 Oct; 26():74-80. PubMed ID: 28780440
[TBL] [Abstract][Full Text] [Related]
33. Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system.
Garner-Hamrick PA; Fostel JM; Chien WM; Banerjee NS; Chow LT; Broker TR; Fisher C
J Virol; 2004 Sep; 78(17):9041-50. PubMed ID: 15308700
[TBL] [Abstract][Full Text] [Related]
34. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
35. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line.
Flores ER; Allen-Hoffmann BL; Lee D; Sattler CA; Lambert PF
Virology; 1999 Sep; 262(2):344-54. PubMed ID: 10502513
[TBL] [Abstract][Full Text] [Related]
36. Presence of human papilloma virus, herpes simplex virus and Epstein-Barr virus DNA in oral biopsies from Sudanese patients with regard to toombak use.
Jalouli J; Ibrahim SO; Sapkota D; Jalouli MM; Vasstrand EN; Hirsch JM; Larsson PA
J Oral Pathol Med; 2010 Sep; 39(8):599-604. PubMed ID: 20618612
[TBL] [Abstract][Full Text] [Related]
37. hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis.
Terrin L; Dolcetti R; Corradini I; Indraccolo S; Dal Col J; Bertorelle R; Bonaldi L; Esposito G; De Rossi A
Int J Cancer; 2007 Aug; 121(3):576-87. PubMed ID: 17417773
[TBL] [Abstract][Full Text] [Related]
38. Using Organotypic Epithelial Tissue Culture to Study the Human Papillomavirus Life Cycle.
Lee D; Norby K; Hayes M; Chiu YF; Sugden B; Lambert PF
Curr Protoc Microbiol; 2016 May; 41():14B.8.1-14B.8.19. PubMed ID: 27153383
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus permissively infects human syncytiotrophoblasts in vitro and induces replication of human T cell leukemia-lymphoma virus type I in dually infected cells.
Tóth FD; Aboagye-Mathiesen G; Nemes J; Liu X; Andirkó I; Hager H; Zdravkovic M; Szabó J; Kiss J; Aranyosi J; Ebbesen P
Virology; 1997 Mar; 229(2):400-14. PubMed ID: 9126252
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms by which HPV Induces a Replication Competent Environment in Differentiating Keratinocytes.
Moody C
Viruses; 2017 Sep; 9(9):. PubMed ID: 28925973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
